Trials / Conditions / Amyloid Beta Protein
Amyloid Beta Protein
5 registered clinical trials studyying Amyloid Beta Protein — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation NCT06911944 | Michael Rafii, MD, PhD | Phase 4 |
| Completed | Escitalopram Effects on CSF Amyloid Beta NCT02161458 | University of Pennsylvania | Phase 4 |
| Completed | Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid. NCT00928304 | Life Molecular Imaging SA | Phase 2 |
| Completed | Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patie NCT00750282 | Life Molecular Imaging SA | Phase 2 |
| Completed | Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patient NCT01138111 | Life Molecular Imaging SA | Phase 1 |